Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001293

Drug Information
SynonymsSalicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester); Nitazoxanid; SMR000466367; N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester); Colufase; Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide; Nitazoxanida; o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate; LS-144176; NSC 697855; Taenitaz; NSC697855; Daxon; Alinia; 2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide; Nitazoxanida [INN-Spanish]; NCGC00090774-01; Alinia (TN); Nitazoxanidum; STK395664; NITAZOXANIDE; MolPort-002-042-244; azt+ nitazoxanide; CHEMBL1401; Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-; Cryptaz; FT-0082459; I14-6011; Tizoxanide glucuronide; [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate; AC1Q5NVY; CID41684; C12H9N3O5S; SAM001246708; Nitazoxanide [USAN:INN]; D02486; ZINC03956788; EINECS 259-931-8; Nitazoxanide (USAN/INN); CPD000466367; Oprea1_263587; AC1L26A1; DB00507; 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide; BRN 1225475; 2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate; UNII-SOA12P041N; Phavic-1; (2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat; AZT + Nitazoxanide; 55981-09-4; NCI60_034935; AC-1302; SBB068315; HMS2051L04; N-(5-Nitrothiazol-2-yl)salicylamide acetate ester; MLS000759492; Nitazoxanidum [INN-Latin]; MLS001424074; S1627_Selleck; NCIMech_000843; Heliton; 2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide; Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Trade NameAlinia; Annita; Daxon; Dexidex; Kidonax; Pacovanton; Paramix; Nitax; Zox; Nitazox
CompanyUnimed Pharmaceuticals
[ICD9: 787.91   ICD10: A09, K59.1]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]    
Therapeutic ClassAntiparasitic Agents
CAS NumberCAS 55981-09-4
PubChem Compound IDCID 41684.
PubChem Substance IDSID 182380.
SuperDrug ATC IDP01AX11
TargetParasitic pyruvate:ferredoxin oxidoreductaseInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021497 To Reference
Ref 2Flavodoxin:quinone reductase (FqrB): a redox partner of pyruvate:ferredoxin oxidoreductase that reversibly couples pyruvate oxidation to NADPH production in Helicobacter pylori and Campylobacter jejuni. J Bacteriol. 2007 Jul;189(13):4764-73. Epub 2007 Apr 27. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543